Lead party: EuroMena (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Biopharm Group (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria
Transaction type: Investment · Asset class: Private Equity · Strategy: Strategic Minority · Instrument: Equity · Fund: EuroMena Fund II
Lead investor/buyer: EuroMena · Investors/buyers: EuroMena
Legal advisers: not identified in the source record.
Source: announced 1 December 2013. Original announcement: euromenafunds.com.


